Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition PA Clark, M Iida, DM Treisman, H Kalluri, S Ezhilan, M Zorniak, ... Neoplasia 14 (5), 420-IN13, 2012 | 175 | 2012 |
The cancer stem cell paradigm: a new understanding of tumor development and treatment JD Ebben, DM Treisman, M Zorniak, RG Kutty, PA Clark, JS Kuo Expert opinion on therapeutic targets 14 (6), 621-632, 2010 | 142 | 2010 |
Developmental signaling pathways in brain tumor‐derived stem‐like cells PA Clark, DM Treisman, J Ebben, JS Kuo Developmental Dynamics: An Official Publication of the American Association …, 2007 | 100 | 2007 |
Opposing tumor-promoting and-suppressive functions of rictor/mTORC2 signaling in adult glioma and pediatric SHH medulloblastoma S Akgül, Y Li, S Zheng, M Kool, DM Treisman, C Li, Y Wang, S Gröbner, ... Cell reports 24 (2), 463-478. e5, 2018 | 26 | 2018 |
Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution Y Li, B Li, W Li, Y Wang, S Akgül, DM Treisman, KA Heist, BR Pierce, ... Nature communications 11 (1), 3669, 2020 | 19 | 2020 |
Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors ES Jecrois, W Zheng, M Bornhorst, Y Li, DM Treisman, D Muguyo, ... Developmental Cell 56 (20), 2871-2885. e6, 2021 | 18 | 2021 |
Sox2+ cells in Sonic Hedgehog-subtype medulloblastoma resist p53-mediated cell-cycle arrest response and drive therapy-induced recurrence DM Treisman, Y Li, BR Pierce, C Li, AP Chervenak, GJ Tomasek, ... Neuro-oncology advances 1 (1), vdz027, 2019 | 10 | 2019 |
Stem-like cell populations, p53-pathway activation and mechanisms of recurrence in sonic hedgehog medulloblastoma D Treisman, Y Li, Y Zhu NeuroMolecular Medicine 24 (1), 13-17, 2022 | 5 | 2022 |
A therapeutic window for preventive therapy in NF1-associated optic pathway glioma Y Zhu, W Zheng, ES Jecrois, BR Pierce, DM Treisman Molecular & Cellular Oncology 8 (6), 1989262, 2021 | 1 | 2021 |
Tumor Suppressor p53 in Cerebellar Development, Medulloblastoma Initiation, and Treatment Resistance. D Treisman | | 2016 |